Ingalls & Snyder LLC’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,540
| Closed | -$43K | – | 443 |
|
|
2021
Q2 | $43K | Hold |
1,540
| – | – | ﹤0.01% | 432 |
|
|
2021
Q1 | $34K | Hold |
1,540
| – | – | ﹤0.01% | 416 |
|
|
2020
Q4 | $22K | Sell |
1,540
-770
| -33% | -$11K | ﹤0.01% | 406 |
|
|
2020
Q3 | $35K | Hold |
2,310
| – | – | ﹤0.01% | 352 |
|
|
2020
Q2 | $48K | Hold |
2,310
| – | – | ﹤0.01% | 384 |
|
|
2020
Q1 | $44K | Sell |
2,310
-160
| -6% | -$3.05K | ﹤0.01% | 389 |
|
|
2019
Q4 | $71K | Sell |
2,470
-5,690
| -70% | -$164K | ﹤0.01% | 378 |
|
|
2019
Q3 | $417K | Sell |
8,160
-640
| -7% | -$32.7K | 0.02% | 305 |
|
|
2019
Q2 | $697K | Sell |
8,800
-80
| -0.9% | -$6.34K | 0.03% | 250 |
|
|
2019
Q1 | $586K | Hold |
8,880
| – | – | 0.03% | 263 |
|
|
2018
Q4 | $493K | Buy |
8,880
+5,230
| +143% | +$290K | 0.03% | 275 |
|
|
2018
Q3 | $330K | Buy |
+3,650
| New | +$330K | 0.01% | 334 |
|